The team

Executive Leaders

Dr Harris Eyre MD

HARRIS A. EYRE

Chief Medical Officer

MD, PhD, Fulbright Scholar (UCLA; W.G. Walker). "I joined CNSDose to promote our evidence-based, scalable and personalized technology to reduce the suffering caused by trial-and-error prescribing. I look forward to our bringing other high-value mental health solutions to the market". Harris specialises in psychiatry and neuroscience innovation. He brings a diverse background converging his experience in clinical psychiatry, neuroscience, clinical research, diplomacy, public health, health system management and technology. Harris has published 80 scientific articles, presents frequently at international conferences, peer-reviews top scientific journals. He is Entrepreneur-in-Residence at the Texas Medical Center Innovation Institute, as well as an Honorary Research Fellow with The University of Melbourne, The University of Adelaide and Deakin University.

stub

Mark Heinemeyer

Chief Executive Officer

"I was drawn to CNSDose because of the staggering burden that untreated depression places on people and on our economy, and the profound impact we can make." Mark is a senior healthcare informatics executive who has led global companies, health tech start-ups, growth companies, IPO's and strategic acquisitions. He has long focused in personalized and precision medicine utilizing machine learning, AI and behavioural science to improve health outcomes. An experienced CEO, he has held senior positions with companies such as NantHealth (global genomic medicine company), Fiserv, HCA, Cigna, CorVel, and Global Care Quest plus Board positions with several precision medicine companies.

stub

Hayden Pitout

Chief Technology Officer

Hayden is an internationally experienced software developer. He brings a depth of software development experience from a wide range of industries, web related technologies, coding languages, and systems methodologies. He’s led the delivery of projects at large corporate, private agency, and startup levels. Hayden has significant international experience, including being IT lead for GE Capital where he won multiple highly competitive awards for software engineering excellence. He brings both technical experience and excellent inter-personal communication skills to spearhead development of both the CNSDose software platform and growth of the CNSDose software development team.

Board of Directors

A/Prof Ajeet B Singh MD

A/Prof Ajeet B Singh

Director

Ajeet (MD, PhD, MPsych, FRANZCP) is an academic private psychiatrist who was awarded his medical degree, masters, and doctorate from The University of Melbourne. His research has focused on genetically guided prescribing (pharmacogenetics) of antidepressants, particularly the role of the blood-brain-barrier. He’s an academic member of the Clinical Pharmacogenetics Implementation Consortium (CPIC) and member of the Genetic Tests in Psychiatry Taskforce, International Society of Psychiatric Genetics (ISPG). Dr. Singh is also the Founder of CNSDose.

stub

Andrew Robb AO

Chairman

Andrew is the former Federal Trade Minister of Australia. He held the Federal seat of Goldstein from 2004 till his retirement from politics in 2016. In 2003 he was awarded the Office of the Order of Australia (AO) for his services to agriculture, politics and the community. In the 1980’s he was Executive Director of the Cattle Council of Australia, and later, Executive Director of the National Farmers' Federation. He has an Agricultural Science and First Class Honours Degree in Economics. Andrew served as a director of The Garvan Institute for Medical Research, Australia. He provides strategic advice on trade and investment, serving on the boards of several major Australian and International companies.

stub

Prof John Tiller

Director

John (MD, MBChB, BSc, DPM, FRACP, FRANZCP, GAICD) is the immediate past Head of the Department of Psychiatry and Professor Emeritus, The University of Melbourne. He’s an internationally respected academic and clinical psychiatrist, with over 300 publications. He has a particular interest in the quality treatment of depressive illness. John is also an experienced Company Director and active member of the Australian Institute of Company Directors (AICD). He continues in clinical practice and to teach at the University of Melbourne. He is an examiner for the flagship AICD Company Directors Course - helping to set and maintain standards for directors in all areas of directorship.